Basic Information
| LncRNA/CircRNA Name | LINCRNA-p21 |
| Synonyms | TP53COR1, TRP53COR1, linc-p21, lincRNA-p21 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | brown seaweed oligo-fucoidan | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot, in vitro knockdown, etc. |
| Sample | HepG2 cell, the human liver cancer cell line |
| Expression Pattern | differential expression |
| Function Description | lncRNAs switched oligofucoidan- induced apoptosis, which might be potentially valuable in HCC adjuvant therapy. |
| Pubmed ID | 30632031 |
| Year | 2019 |
| Title | The anti-tumor activity of brown seaweed oligo-fucoidan via lncRNA expression modulation in HepG2 cells |
External Links
| Links for LINCRNA-p21 | GenBank HGNC NONCODE |
| Links for Hepatocellular carcinoma | OMIM COSMIC |